Curcumin Enhances the Anti-obesogenic Activity of Orlistat Through SKN-1/NRF2-dependent Regulation of Nutrient Metabolism in Caenorhabditis Elegans

Overview

Journal Int J Obes (Lond)

Date 2025 Jan 24

PMID 39856245

Authors

Martina S Savova

Monika N Todorova

Biser K Binev

Milen I Georgiev

Liliya V Mihaylova

Affiliations

Soon will be listed here.

Abstract

Background: Metabolic dysregulation, a defining feature of obesity, disrupts essential signalling pathways involved in nutrient sensing and mitochondria homeostasis. The nuclear factor erythroid 2-related factor 2 (NRF-2) serves as a pivotal regulator of the cellular stress response, and recent studies have implicated it in the pathogenesis of obesity, diabetes, and metabolic syndrome. Curcumin, a polyphenolic compound derived from turmeric, has been identified as a potent activator of NRF-2. Evidence suggests curcumin impacts obesity and metabolic disorders by modulating gut microbiota composition, increasing energy expenditure, and regulating lipid metabolism. Orlistat, an anti-obesity drug, inhibits fat absorption in the gastrointestinal tract, but its side effects limits its broader use.

Objectives: The present study aims to investigate the potential synergetic effect of a hybrid combination between orlistat and curcumin. Additionally, we provide a detailed understanding of the molecular mechanisms through which this combination mitigates glucose-induced lipid accumulation in Caenorhabditis elegans, with a focus on the role of the skinhead 1 (SKN-1) transcription factor, an orthologue of NRF2.

Methods: We assessed the lipid accumulation and the changes in skn-1 transcriptional activity in C. elegans using confocal GFP-based detection, alongside mRNA expression analysis of genes from lipid metabolism and oxidative stress response in wild-type, QV225 and LD1 strains. Furthermore, we evaluated locomotion, chemotaxis and mitochondrial dynamics to enhance our understanding of the proposed molecular-based model.

Results: Our findings reveal that the orlistat/curcumin combination exerts an anti-obesogenic effect through SKN-1/NRF2-dependent regulation of conserved genes involved in carbohydrate and lipid metabolism in C. elegans. Moreover, the combination stimulates mitochondrial potential, further contributing to the observed synergistic effects.

Conclusion: The hybrid combination of orlistat and curcumin demonstrates significant anti-obesity activity by regulating nutrient-sensing pathways through SKN-1/NRF-2 modulation. This approach may allow for the reduction of orlistat dosage, thereby minimizing its adverse effects while maintaining its therapeutic efficacy.

References

Savova M, Mihaylova L, Tews D, Wabitsch M, Georgiev M . Targeting PI3K/AKT signaling pathway in obesity. Biomed Pharmacother. 2023; 159:114244. DOI: 10.1016/j.biopha.2023.114244. View

Muller T, Bluher M, Tschop M, DiMarchi R . Anti-obesity drug discovery: advances and challenges. Nat Rev Drug Discov. 2021; 21(3):201-223. PMC: 8609996. DOI: 10.1038/s41573-021-00337-8. View

Zhao X, Wang J, Neely G, Shi Y, Wang Q . Natural compounds as obesity pharmacotherapies. Phytother Res. 2023; 38(2):797-838. DOI: 10.1002/ptr.8083. View

Holmback U, Gruden S, Litorp H, Willhems D, Kuusk S, Alderborn G . Effects of a novel weight-loss combination product containing orlistat and acarbose on obesity: A randomized, placebo-controlled trial. Obesity (Silver Spring). 2022; 30(11):2222-2232. PMC: 9826204. DOI: 10.1002/oby.23557. View

Longo V, Di Tano M, Mattson M, Guidi N . Intermittent and periodic fasting, longevity and disease. Nat Aging. 2022; 1(1):47-59. PMC: 8932957. DOI: 10.1038/s43587-020-00013-3. View

Weir H, Yao P, Huynh F, Escoubas C, Goncalves R, Burkewitz K . Dietary Restriction and AMPK Increase Lifespan via Mitochondrial Network and Peroxisome Remodeling. Cell Metab. 2017; 26(6):884-896.e5. PMC: 5718936. DOI: 10.1016/j.cmet.2017.09.024. View

Madeo F, Carmona-Gutierrez D, Hofer S, Kroemer G . Caloric Restriction Mimetics against Age-Associated Disease: Targets, Mechanisms, and Therapeutic Potential. Cell Metab. 2019; 29(3):592-610. DOI: 10.1016/j.cmet.2019.01.018. View

Atanasov A, Zotchev S, Dirsch V, Supuran C . Natural products in drug discovery: advances and opportunities. Nat Rev Drug Discov. 2021; 20(3):200-216. PMC: 7841765. DOI: 10.1038/s41573-020-00114-z. View

Thomas C, Erni R, Wu J, Fischer F, Lamers G, Grigolon G . A naturally occurring polyacetylene isolated from carrots promotes health and delays signatures of aging. Nat Commun. 2023; 14(1):8142. PMC: 10709416. DOI: 10.1038/s41467-023-43672-7. View

10.

Bolger G, Pucaj K, Minta Y, Sordillo P . Relationship between the in vitro efficacy, pharmacokinetics and in vivo efficacy of curcumin. Biochem Pharmacol. 2022; 205:115251. DOI: 10.1016/j.bcp.2022.115251. View

11.

Vasileva L, Saracheva K, Ivanovska M, Petrova A, Marchev A, Georgiev M . Antidepressant-like effect of salidroside and curcumin on the immunoreactivity of rats subjected to a chronic mild stress model. Food Chem Toxicol. 2018; 121:604-611. DOI: 10.1016/j.fct.2018.09.065. View

12.

Shin J, Chun K, Kim D, Kim S, Kim S, Cho N . Curcumin induces stabilization of Nrf2 protein through Keap1 cysteine modification. Biochem Pharmacol. 2020; 173:113820. DOI: 10.1016/j.bcp.2020.113820. View

13.

Ren L, Zhan P, Wang Q, Wang C, Liu Y, Yu Z . Curcumin upregulates the Nrf2 system by repressing inflammatory signaling-mediated Keap1 expression in insulin-resistant conditions. Biochem Biophys Res Commun. 2019; 514(3):691-698. DOI: 10.1016/j.bbrc.2019.05.010. View

14.

Li N, Yan X, Huang W, Chu M, Dong Y, Song H . Curcumin protects against the age-related hearing loss by attenuating apoptosis and senescence via activating Nrf2 signaling in cochlear hair cells. Biochem Pharmacol. 2023; 212:115575. DOI: 10.1016/j.bcp.2023.115575. View

15.

Wu X, Zhou X, Lai S, Liu J, Qi J . Curcumin activates Nrf2/HO-1 signaling to relieve diabetic cardiomyopathy injury by reducing ROS in vitro and in vivo. FASEB J. 2022; 36(9):e22505. DOI: 10.1096/fj.202200543RRR. View

16.

Vasileva L, Savova M, Amirova K, Dinkova-Kostova A, Georgiev M . Obesity and NRF2-mediated cytoprotection: Where is the missing link?. Pharmacol Res. 2020; 156:104760. DOI: 10.1016/j.phrs.2020.104760. View

17.

Frankino P, Siddiqi T, Bolas T, Bar-Ziv R, Gildea H, Zhang H . SKN-1 regulates stress resistance downstream of amino catabolism pathways. iScience. 2022; 25(7):104571. PMC: 9240870. DOI: 10.1016/j.isci.2022.104571. View

18.

Pang S, Lynn D, Lo J, Paek J, Curran S . SKN-1 and Nrf2 couples proline catabolism with lipid metabolism during nutrient deprivation. Nat Commun. 2014; 5:5048. PMC: 4205844. DOI: 10.1038/ncomms6048. View

19.

Blackwell T, Steinbaugh M, Hourihan J, Ewald C, Isik M . SKN-1/Nrf, stress responses, and aging in Caenorhabditis elegans. Free Radic Biol Med. 2015; 88(Pt B):290-301. PMC: 4809198. DOI: 10.1016/j.freeradbiomed.2015.06.008. View

20.

Costa R, Dias M, Alves J, Silva J, Rodrigues D, Silva J . Pharmacological activation of nuclear factor erythroid 2-related factor-2 prevents hyperglycemia-induced renal oxidative damage: Possible involvement of O-GlcNAcylation. Biochem Pharmacol. 2023; 220:115982. DOI: 10.1016/j.bcp.2023.115982. View